DGH-GO: dissecting the genetic heterogeneity of complex diseases using gene ontology
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
DGH-GO: dissecting the genetic heterogeneity of complex diseases using gene ontology ; volume:24 ; number:1 ; day:26 ; month:4 ; year:2023 ; pages:1-20 ; date:12.2023
BMC bioinformatics ; 24, Heft 1 (26.4.2023), 1-20, 12.2023
- Urheber
-
Asif, Muhammad
Martiniano, Hugo F. M. C.
Lamurias, Andre
Kausar, Samina
Couto, Francisco M.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12859-023-05290-4
- URN
-
urn:nbn:de:101:1-2023090410153927363863
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 10:45 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Asif, Muhammad
- Martiniano, Hugo F. M. C.
- Lamurias, Andre
- Kausar, Samina
- Couto, Francisco M.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Dissecting the genetic heterogeneity of gastric cancer
Dissecting Fibroblast Heterogeneity in Health and Fibrotic Disease
Mitochondrial heterogeneity in diseases
Dissecting the heterogeneity of murine mesenchymal bone marrow stromal cells
Dissecting regional heterogeneity and modeling transcriptional cascades in brain organoids
Dissecting human adipose tissue heterogeneity using single‐cell omics technologies
The Gene Ontology (GO) Cellular Component Ontology: integration with SAO (Subcellular Anatomy Ontology) and other recent developments
Dissecting limb regeneration and cancer heterogeneity using single-cell RNA-seq
Dissecting Psychiatric Heterogeneity and Comorbidity with Core Region-Based Machine Learning
Dissecting clinical heterogeneity of bipolar disorder using multiple polygenic risk scores
Dissecting population and single-cell heterogeneity in response to anti-cancer drugs
Dissecting the heterogeneity of “in the wild” stress from multimodal sensor data
Dissecting the genetic heterogeneity of gastric cancer
Dissecting Fibroblast Heterogeneity in Health and Fibrotic Disease
Mitochondrial heterogeneity in diseases
Dissecting the heterogeneity of murine mesenchymal bone marrow stromal cells
Dissecting regional heterogeneity and modeling transcriptional cascades in brain organoids
Dissecting human adipose tissue heterogeneity using single‐cell omics technologies
The Gene Ontology (GO) Cellular Component Ontology: integration with SAO (Subcellular Anatomy Ontology) and other recent developments
Dissecting limb regeneration and cancer heterogeneity using single-cell RNA-seq
Dissecting Psychiatric Heterogeneity and Comorbidity with Core Region-Based Machine Learning
Dissecting clinical heterogeneity of bipolar disorder using multiple polygenic risk scores
Dissecting population and single-cell heterogeneity in response to anti-cancer drugs
Dissecting the heterogeneity of “in the wild” stress from multimodal sensor data
Dissecting the genetic heterogeneity of gastric cancer
Dissecting Fibroblast Heterogeneity in Health and Fibrotic Disease
Mitochondrial heterogeneity in diseases
Dissecting the heterogeneity of murine mesenchymal bone marrow stromal cells
Dissecting regional heterogeneity and modeling transcriptional cascades in brain organoids
Dissecting human adipose tissue heterogeneity using single‐cell omics technologies
The Gene Ontology (GO) Cellular Component Ontology: integration with SAO (Subcellular Anatomy Ontology) and other recent developments
Dissecting limb regeneration and cancer heterogeneity using single-cell RNA-seq
Dissecting Psychiatric Heterogeneity and Comorbidity with Core Region-Based Machine Learning
Dissecting clinical heterogeneity of bipolar disorder using multiple polygenic risk scores
Dissecting population and single-cell heterogeneity in response to anti-cancer drugs